Schear Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,023
Closed -$720K 88
2025
Q1
$720K Sell
8,023
-246
-3% -$23K 0.41% 65
2024
Q4
$823K Sell
8,269
-2,313
-22% -$238K 0.44% 63
2024
Q3
$1.2M Buy
10,582
+1,565
+17% +$186K 0.74% 48
2024
Q2
$1.12M Buy
9,017
+2,377
+36% +$306K 0.81% 41
2024
Q1
$876K Buy
6,640
+3,407
+105% +$420K 0.7% 53
2023
Q4
$352K Buy
3,233
+445
+16% +$46.2K 0.34% 67
2023
Q3
$287K Hold
2,788
0.31% 71
2023
Q2
$322K Buy
2,788
+413
+17% +$46.9K 0.34% 72
2023
Q1
$253K Hold
2,375
0.3% 78
2022
Q4
$264K Buy
+2,375
New +$243K 0.33% 84

Other funds holding MRK

Schear Investment Advisers's MRK Position: Q2 2025 in Review

Schear Investment Advisers sold out of Merck (MRK) in Q2 2025, closing a stake of 8,023 shares — an estimated $720K sold.

Schear Investment Advisers first reported a position in MRK in Q4 2022 and held it in 10 quarters. The position peaked at $1.2M in Q3 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Schear Investment Advisers reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Schear Investment Advisers sold 8,023 Merck shares in Q2 2025, an estimated $720K.
  • Schear Investment Advisers first reported a position in Merck in Q4 2022 and held it in 10 quarters.
  • Schear Investment Advisers's Merck position peaked at $1.2M in Q3 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Schear Investment Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.